Does CyberKnife improve dose distribution versus IMRT and VMAT on a linear accelerator in low-risk prostate cancer? CyberKnife, IMRT and VMAT in low risk prostate cancer. Radiology and Oncology, v. 56, n. 2, p. 259–266, 3 Jul.2022.